SciELO - Scientific Electronic Library Online

 
vol.21 número1INDICADORES DE RIESGO LABORAL POR EXPOSICIÓN AL HALOTANO EN EL HOSPITAL CLÍNICO VIEDMA VERSUS PEDIATRÍAACRETISMO PLACENTARIO: DIAGNOSTICO PRENATAL MEDIANTE ESTUDIO ECOGRÁFICO DOPPLER EN EL HOSPITAL MATERNO INFANTIL índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

    Links relacionados

    • No hay articulos citadosCitado por SciELO
    • No hay articulos similaresSimilares en SciELO

    Bookmark

    Revista médica (Cochabamba)

    versión impresa ISSN 2074-4609

    Resumen

    MENDEZ DELGADILLO, Litzy M.; PARDO NOVAK, Antonio  y  URIONA ARCE, Remy R.. LEVELS OF MAGNESEMIA IN THE MANAGEMENT OF PREGNANT WOMEN WITH SEVERE PRE-ECLAMPSIA TREATED WITH MAGNESIUM SULPHATE. Rev. méd. (Cochabamba) [online]. 2010, vol.21, n.1, pp. 39-45. ISSN 2074-4609.

    Severe preclampsia is a pathology that affects 3% of the pregnant women hospitalized in our hospital and its correct management is highly valuable for the high risk of morbi mortality that represents for the mother - child binomial. The present study was made in a group of pregnant women with severe preclampsia that were treated at Maternoinfantil Germán Urquidi hospital and who received magnesium sulphate as treatment, with doses according protocols of the SUMI. The dosis were controlled with levels of magnesemia to determine the reached therapeutic ranks. We concluded that none of the patients of this study, reached magnesium therapeutic levels, with interrupted a magnesium sulphate administration in the service of dilatantes to 2-6 hrs de initiated in treatment; the patients did not present clinical manifestations of intoxication by magnesium and most of them had a conserved renal function. Many of the patients were between the 16 - 25 years, attending his first gestation, with pregnancies majors to 34 weeks in predominant form. We recommend to modify the administration protocols of magnesium sulphate to 6gr./ charge dose and 2gr. /hr maintenance infusion, with laboratory controls to control the reached therapeutic ranks in each patient.

    Palabras llave : Magnesium sulphate; severe preeclampsia; levels of magnesemia.

            · resumen en español     · texto en español     · pdf en español